GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Aegerion Pharmaceuticals, Inc. (AEGR) [hlAlert]

Aegerion Pharmaceuticals, Inc. (Aegerion) is a biopharmaceutical company focused on the development and commercialization of therapeutics to treat severe lipid disorders. Its lead compound, lomitapide, is a microsomal triglyceride transfer protein inhibitor (MTP-I), which limits secretion
of cholesterol and triglycerides from the intestines and the liver, the main sources of lipids in the body. The Company is initially developing lomitapide as an oral, once-a-day treatment for patients with a rare genetic lipid disorder called homozygous familial hypercholesterolemia (HoFH). HoFH is a genetic lipid disorder caused by defects in both copies of the low-density lipoprotein (LDL) receptor genes, resulting in impaired or total loss of function in the LDL receptor.
( Total: 12 Current Stock Recommendations )
Aegerion Pharmaceuticals, Inc.   (12)
Hold Buy 92%
Related companies
China Biologic ...   (4)
Buy 100%
ATHERSYS INC   (7)
Buy 100%
ACURA PHARMACEUTICAL   (2)
Buy 100%
BioSpecifics ...   (5)
Buy 100%
Derma Sciences, Inc.   (2)
Buy 100%
Tenax Therapeutics ...   (2)
Buy 100%
ARCA BIOPHARMA INC.   (1)
Buy 100%
PROLOR Biotech, Inc.   (5)
Buy 100%
Opko Health Inc   (2)
Buy 100%
Nutraceutical ...   (1)
Buy 100%
Filter by Gains:   
  
Rating:
Buy AEGR
up 75.66 %
Aegerion Pharmaceuticals, Inc. (AEGR) rated Buy by Guggenheim
Monday,  Dec 21, 2015  10:25 AM ET

Rating:
Hold AEGR
down 76.74 %

Rating:
Buy AEGR
down 76.74 %

Rating:
Buy AEGR
down 81.39 %

Rating:
Buy AEGR
down 81.39 %

Rating:
Buy AEGR
up 24.80 %

Rating:
Buy AEGR
up 18.32 %

Rating:
Buy AEGR
up 18.32 %

Rating:
Buy AEGR
up 24.80 %

Rating:
Buy AEGR
up 18.32 %

Rating:
Buy AEGR
down 47.61 %
Aegerion Pharmaceuticals, Inc. (AEGR) rated Buy by BofA/Merrill
Tuesday,  Mar 5, 2013  8:25 AM ET

Rating:
Buy AEGR
down 47.61 %
Aegerion Pharmaceuticals, Inc. (AEGR) rated Buy by Jefferies
Tuesday,  Mar 5, 2013  8:25 AM ET

Rating:
Buy AEGR
down 34.89 %
Aegerion Pharmaceuticals, Inc. (AEGR) rated Buy by Lazard
Monday,  Feb 11, 2013  8:25 AM ET

Rating:
Buy AEGR
up 18.32 %

Rating:
Buy AEGR
up 22.48 %

Your Recent Stocks
SymbolLastChange
AEGR 1.91 down  -89.24 %

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy